VAS
PRAX icon

Vestmark Advisory Solutions’s Praxis Precision Medicines PRAX Stock Holding History

Vestmark Advisory Solutions’s Portfolio PRAX Stock Details PRAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.24M Hold
6,681
– – 0.02% 667
2026
Q1 		$2.15M Buy
6,681
+2,176
+48% +$673K 0.02% 601
2025
Q4 		$1.33M Buy
+4,505
New +$839K 0.02% 716

Other funds holding PRAX

JT
Jupiter Topco New York $245B AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

Vestmark Advisory Solutions's PRAX Position: Q2 2026 in Review

Vestmark Advisory Solutions held its Praxis Precision Medicines (PRAX) position steady in Q2 2026 at 6,681 shares worth $2.24M. The position accounts for 0.02% of the portfolio, ranked #667.

Vestmark Advisory Solutions first reported a position in PRAX in Q4 2025 and has held it in 3 quarters since. 310 funds tracked by Wall St. Rank hold PRAX as of Q2 2026.

  • Vestmark Advisory Solutions held 6,681 shares of Praxis Precision Medicines worth $2.24M as of Q2 2026.
  • Vestmark Advisory Solutions left its Praxis Precision Medicines share count unchanged in Q2 2026.
  • Praxis Precision Medicines made up 0.02% of Vestmark Advisory Solutions's portfolio in Q2 2026, its #667 holding.
  • Vestmark Advisory Solutions first reported a position in Praxis Precision Medicines in Q4 2025 and has held it in 3 quarters since.
  • 310 funds tracked by Wall St. Rank held Praxis Precision Medicines as of Q2 2026.

Based on Vestmark Advisory Solutions's 13F filing for Q2 2026, filed 14 Aug 2026.